What is the appropriate evaluation and management for a patient presenting with clitoral erection?

Clitoral Priapism Management

For a patient presenting with clitoral erection (clitoral priapism), start with oral pseudoephedrine as first-line conservative therapy, and if this fails or symptoms are severe/prolonged, proceed to intracavernosal phenylephrine injection using the same principles established for penile priapism. 1, 2

Initial Assessment

When evaluating clitoral priapism, obtain these specific details:

• Duration of erection - Critical for determining urgency (>4 hours requires more aggressive intervention)
• Degree of rigidity - Fully rigid versus partial tumescence (partial is less urgent)
• Pain severity - Indicates ischemic versus non-ischemic etiology
• Medication history - Particularly trazodone, bupropion (Wellbutrin), and other antidepressants with alpha-adrenergic blockade 2, 3
• Baseline sexual function and any prior episodes
• Underlying conditions - Hematologic disorders, pelvic malignancies, vascular disease 3, 4

Physical examination should focus on the degree of clitoral engorgement, rigidity, and tenderness.

Treatment Algorithm

Conservative Management (First-Line)

Oral pseudoephedrine is the most evidence-based conservative option for clitoral priapism 2. One case report demonstrated complete resolution with around-the-clock oral pseudoephedrine after 5 days of symptoms 2.

Additional conservative measures include:

• Ice packs applied locally 5
• Analgesics for pain control 5
• Immediate cessation of causative medications (most critical intervention) 3

When Conservative Management Fails

Intracavernosal alpha-agonist injection should be the next step, extrapolating from high-quality penile priapism guidelines 1, 4:

• Phenylephrine is preferred - The AUA/SMSNA guidelines strongly support intracavernosal phenylephrine as highly effective for prolonged erections 1
• One case report specifically documented successful treatment of clitoral priapism with intracavernous adrenaline (epinephrine) 4
• This approach mirrors the established treatment for penile priapism, where phenylephrine injection is considered primary therapy when conservative measures fail 1

Critical Timing Considerations

The 4-hour threshold from penile priapism guidelines should guide urgency 1, 6:

• <4 hours with partial rigidity: Conservative management is reasonable
• >4 hours with full rigidity: More aggressive intervention warranted to prevent tissue damage
• Prolonged ischemic priapism leads to tissue fibrosis and permanent dysfunction 6

Common Pitfalls

Do not delay effective treatment with prolonged conservative measures if the erection is fully rigid and >4 hours 1. The guideline explicitly warns against using conservative therapies "in place of, or prolong effective treatments, if more emergent detumescence is required" 1.

Medication withdrawal alone may be insufficient - While stopping the causative agent is essential 3, active intervention is often needed for symptom resolution, as demonstrated in the case where symptoms persisted for 5 days despite stopping trazodone and bupropirin until pseudoephedrine was initiated 2.

Evidence Strength Note

While direct evidence for clitoral priapism is limited to case reports 2, 5, 3, 4, the pathophysiology is identical to penile priapism, and the high-quality AUA/SMSNA guidelines 1, 6 provide the strongest framework for management. The alpha-adrenergic mechanism is the same regardless of anatomical location.